Elon Musk's brain chip firm Neuralink has said it has been given the go-ahead to start carrying out studies on humans. Neuralink said in a tweet on Thursday it had won the approval of the US Food and Drug Administration (FDA) "to launch our first-in-human clinical study!" The company did not elaborate on the aims of the study, or when trials will start, but said it was not recruiting yet. The billionaire has said Neuralink would begin human trials at least four times since 2019, but the company only applied for FDA approval early last year. Neuralink hopes the implant it is developing will help paralysed people walk again - and cure other neurological issues.

Source: Daily Nation May 26, 2023 23:29 UTC